Protocol Ledger

NCT06490536 · Phase III · RECRUITING

The Sagittarius Trial

Interventional Phase III clinical trial protocol NCT06490536 sponsored by IFOM ETS - The AIRC Institute of Molecular Oncology in Oncology and Hematology, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2024-10-22 Enrollment: 700 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT06490536
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)700 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT06490536
Protocol FieldVerified Registry Value
NCT IdentifierNCT06490536
Consolidated Lead SponsorIFOM ETS - The AIRC Institute of Molecular Oncology
Therapeutic Condition CohortOncology and Hematology
Clinical Trial PhasePhase III
Overall Recruitment StatusRECRUITING
Registered Enrollment700 participants (ESTIMATED)
Registered Start Date2024-10-22
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT06490536
Hospital Research SiteLocationSite Profile
Charité Universitätsmedizin BerlinBerlin, GermanyOpen Hospital Dossier ->
Istituto Europeo di OncologiaMilan, ItalyOpen Hospital Dossier ->
Istituto Clinico HumanitasRozzano, ItalyOpen Hospital Dossier ->
Hospital del MarBarcelona, SpainOpen Hospital Dossier ->

Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI